31 results
8-K
EX-99.1
SAVA
Cassava Sciences Inc
3 Aug 22
Cassava Sciences Reports Second Quarter Financial Results for 2022, Mid-year Corporate Update and Interim Analysis of Open-label Study
9:25am
to evaluate an innovative method to detect FLNA without the use of antibodies. For business, technical and personnel reasons, we continue to prioritize
8-K
EX-99.1
olpwdef s65k0gr
11 Mar 21
Cassava Sciences Announces Pharmaceutical Supply Agreement for Simufilam
4:59pm
8-K
EX-99.1
eaq3dcpaft0v cj7b72
25 Mar 19
Pain Therapeutics Reports 2018 Financial Results and Corporate Update
12:00am
8-K
EX-99.1
xxhed ke97muoaekk
8 Feb 19
Pain Therapeutics Announces Feedback from
4:04pm
8-K
EX-99.1
xnx983
6 Aug 18
Other Events
7:00am